This is the authors' abstract. We don't add key points for this paper.
Molecularly designed, random copolymer-bioconjugates based on poly(2-methyl-2-oxazoline) (PMOXA) and poly(2-ethyl-2-oxazoline) (PEOXA) are crosslinked in the presence of sortase A (SA) and human articular chondrocytes (hACs), to yield cellularized polymer networks. Their gelation kinetics and mechanical properties are finely tuned by varying the concentration of SA, while a cell viability >90% is achieved after several weeks of culture, even in the absence of any cell-adhesive cue.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Trachsel et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: